These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36298751)
1. The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection. Syre H; Obreque MEB; Dalen I; Riis ÅG; Berg Å; Löhr IH; Sundal J; Kleppe LK; Vadla MS; Lenning OB; Olofsson JS; Mohn KG; Tøndel C; Blomberg B; Trieu MC; Langeland N; Cox RJ Viruses; 2022 Oct; 14(10):. PubMed ID: 36298751 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays. Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
4. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays. Shah J; Liu S; Potula HH; Bhargava P; Cruz I; Force D; Bazerbashi A; Ramasamy R BMC Infect Dis; 2021 Apr; 21(1):325. PubMed ID: 33827460 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Multiplex Bead Assay against Single-Target Assays for Detection of IgG Antibodies to SARS-CoV-2. Mitchell KF; Carlson CM; Nace D; Wakeman BS; Drobeniuc J; Niemeyer GP; Werner B; Hoffmaster AR; Satheshkumar PS; Schuh AJ; Udhayakumar V; Rogier E Microbiol Spectr; 2022 Jun; 10(3):e0105422. PubMed ID: 35647696 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection. El-Khoury JM; Schulz WL; Durant TJS J Appl Lab Med; 2021 Jul; 6(4):1005-1011. PubMed ID: 33822964 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively. Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948 [TBL] [Abstract][Full Text] [Related]
11. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891 [TBL] [Abstract][Full Text] [Related]
12. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698 [TBL] [Abstract][Full Text] [Related]
13. Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin. Emmerich P; Murawski C; Ehmen C; von Possel R; Pekarek N; Oestereich L; Duraffour S; Pahlmann M; Struck N; Eibach D; Krumkamp R; Amuasi J; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Kann S; May J; Tannich E; Deschermeier C Trop Med Int Health; 2021 Jun; 26(6):621-631. PubMed ID: 33666297 [TBL] [Abstract][Full Text] [Related]
14. RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers. Aguilar R; Li X; Crowell CS; Burrell T; Vidal M; Rubio R; Jiménez A; Hernández-Luis P; Hofmann D; Mijočević H; Jeske S; Christa C; D'Ippolito E; Lingor P; Knolle PA; Roggendorf H; Priller A; Yazici S; Carolis C; Mayor A; Schreiner P; Poppert H; Beyer H; Schambeck SE; Izquierdo L; Tortajada M; Angulo A; Soutschek E; Engel P; Garcia-Basteiro A; Busch DH; Moncunill G; Protzer U; Dobaño C; Gerhard M Microbiol Spectr; 2023 Feb; 11(1):e0316522. PubMed ID: 36622140 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort. Wiwe EF; Carlsson ER; Rasmussen CL; Rasmussen P; Ougaard R; Hansen SI; Schiøler T; Kristiansen S; Hansen YB; Hillig T J Appl Lab Med; 2022 May; 7(3):711-726. PubMed ID: 35134936 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2. Johnson M; Wagstaffe HR; Gilmour KC; Mai AL; Lewis J; Hunt A; Sirr J; Bengt C; Grandjean L; Goldblatt D J Clin Virol; 2020 Sep; 130():104572. PubMed ID: 32769024 [TBL] [Abstract][Full Text] [Related]
17. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening. Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays. Harley K; Gunsolus IL J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364 [TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen. Mutantu PN; Ngwe Tun MM; Nabeshima T; Yu F; Mukadi PK; Tanaka T; Tashiro M; Fujita A; Kanie N; Oshiro R; Takazono T; Imamura Y; Hirayama T; Moi ML; Inoue S; Izumikawa K; Yasuda J; Morita K Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574555 [TBL] [Abstract][Full Text] [Related]
20. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays. DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]